Zobrazeno 1 - 10
of 1 734
pro vyhledávání: '"Schinke C"'
Publikováno v:
In Blood 16 July 2015 126(3):425a-425a
Autor:
Akhtar OS; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Szabo A; Division of Biostatistics, Institute of Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Bhatlapenumarthi V; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Forsberg M; Division of Hematological Malignancies, Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, New York, New York, USA., Balev M; Multiple Myeloma and Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA., Patwari A; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Cheruvalath H; Medical College of Wisconsin Medical School, Milwaukee, Wisconsin, USA., Bhutani D; Multiple Myeloma and Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA., Thanendrarajan S; Myeloma Center, University of Arkansas for Medical Science, Little Rock, Arkansas, USA., Dhakal B; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Zangari M; Myeloma Center, University of Arkansas for Medical Science, Little Rock, Arkansas, USA., Patel T; Myeloma Center, University of Arkansas for Medical Science, Little Rock, Arkansas, USA., Shrestha A; Myeloma Center, University of Arkansas for Medical Science, Little Rock, Arkansas, USA., Al-Hadidi S; Myeloma Center, University of Arkansas for Medical Science, Little Rock, Arkansas, USA., Cooper D; Division of Hematological Malignancies, Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, New York, New York, USA., Lentzsch S; Multiple Myeloma and Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA., van Rhee F; Myeloma Center, University of Arkansas for Medical Science, Little Rock, Arkansas, USA., Shah MR; Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Bag A; Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., D'Souza A; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Schinke C; Myeloma Center, University of Arkansas for Medical Science, Little Rock, Arkansas, USA., Chakraborty R; Multiple Myeloma and Amyloidosis Program, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA., Shah N; Division of Hematological Malignancies, Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, New York, New York, USA., Mohan M; Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.
Autor:
Schinke C; University of Arkansas for Medical Sciences, Little Rock, AR, USA., Dhakal B; Medical College of Wisconsin, Milwaukee, WI, USA., Mazzoni S; Cleveland Clinic, Cleveland, OH, USA., Shenoy S; University of California, San Francisco, CA, USA., Scott SA; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Richards T; MD Anderson Cancer Center, Houston, TX, USA., Le HH; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., DeBrosse A; Avalere Health, New York, NY, USA., Okorozo P; Avalere Health, New York, NY, USA., McDowell R; Avalere Health, New York, NY, USA., Patel S; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Bunn J; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Hawks K; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Zhang X; Johnson & Johnson Innovative Medicine, Horsham, PA, USA., Rodriguez C; Mount Sinai School of Medicine, New York, NY, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2024 Aug 23, pp. 1-7. Date of Electronic Publication: 2024 Aug 23.
Autor:
Chakraborty R; Columbia University Irving Medical Center, New York, NY, USA. rc3360@cumc.columbia.edu., Cheruvalath H; Medical College of Wisconsin, Milwaukee, WI, USA., Patwari A; Medical College of Wisconsin, Milwaukee, WI, USA., Szabo A; Medical College of Wisconsin, Milwaukee, WI, USA., Schinke C; University of Arkansas for Medical Sciences, Little Rock, AR, USA., Dhakal B; Medical College of Wisconsin, Milwaukee, WI, USA., Lentzsch S; Columbia University Irving Medical Center, New York, NY, USA., D'Souza A; Medical College of Wisconsin, Milwaukee, WI, USA., Mohyuddin GR; Huntsman Cancer Center, University of Utah, Salt Lake City, UT, USA., Julian K; Huntsman Cancer Center, University of Utah, Salt Lake City, UT, USA., Midha S; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Costello P; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Kaiser M; The Institute of Cancer Research, London, UK., Hing MNL; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Harrison SJ; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Cliff ERS; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Mohan M; Medical College of Wisconsin, Milwaukee, WI, USA.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Aug 12; Vol. 14 (1), pp. 137. Date of Electronic Publication: 2024 Aug 12.
Autor:
Al Hadidi S; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Ababneh O; Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan., Schinke C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Thanendrarajan S; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Bailey C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Tricot G; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Shaughnessy J Jr; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Zhan F; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Sawyer J; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Siegel ER; Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Zangari M; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Barlogie B; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., van Rhee F; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Aug 07. Date of Electronic Publication: 2024 Aug 07.
Autor:
Went M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Duran-Lozano L; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Halldorsson GH; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Gunnell A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Ugidos-Damboriena N; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Law P; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Ekdahl L; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Sud A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Thorleifsson G; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Thodberg M; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Olafsdottir T; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Lamarca-Arrizabalaga A; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Cafaro C; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Niroula A; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Ajore R; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Lopez de Lapuente Portilla A; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Ali Z; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Pertesi M; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden., Goldschmidt H; Department of Internal Medicine V, University of Heidelberg, 69120, Heidelberg, Germany., Stefansdottir L; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Kristinsson SY; Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland., Stacey SN; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Love TJ; Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland., Rognvaldsson S; Landspitali, National University Hospital of Iceland, IS-101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland., Hajek R; University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic., Vodicka P; Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic., Pettersson-Kymmer U; Department of Integrative Medical Biology, Umeå University, SE-901 87, Umeå, Sweden., Späth F; Department of Radiation Sciences, Umeå University, SE-901 87, Umeå, Sweden., Schinke C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Van Rhee F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Sulem P; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Ferkingstad E; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Hjorleifsson Eldjarn G; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Mellqvist UH; Southern Älvsborg Hospital, SE-501 82, Borås, Sweden., Jonsdottir I; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Morgan G; Perlmutter Cancer Center, Langone Health, New York University, New York, NY, USA., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands., Waage A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Box 8905, N-7491, Trondheim, Norway., Weinhold N; Department of Internal Medicine V, University of Heidelberg, 69120, Heidelberg, Germany.; German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany., Thomsen H; MSB Medical School Berlin, Berlin, Germany., Försti A; German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany.; Hopp Children's Cancer Center, Heidelberg, Germany., Hansson M; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden.; Section of Hematology, Sahlgrenska University Hospital, Gothenburg, SE-413 45, Sweden.; Skåne University Hospital, SE-221 85, Lund, Sweden., Juul-Vangsted A; Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark., Thorsteinsdottir U; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland., Hemminki K; German Cancer Research Center (DKFZ), D-69120, Heidelberg, Germany.; Faculty of Medicine in Pilsen, Charles University, 30605, Pilsen, Czech Republic., Kaiser M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK., Rafnar T; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland., Stefansson K; deCODE Genetics/Amgen, Sturlugata 8, IS-101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, IS-101, Reykjavik, Iceland., Houlston R; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. richard.houlston@icr.ac.uk., Nilsson B; Department of Laboratory Medicine, Lund University, SE-221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.; Lund Stem Cell Center, Lund University, SE-221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.; Broad Institute, 415 Main Street, Cambridge, MA, 02142, USA. bjorn.nilsson@med.lu.se.
Publikováno v:
Nature communications [Nat Commun] 2024 Aug 05; Vol. 15 (1), pp. 6644. Date of Electronic Publication: 2024 Aug 05.
Autor:
Sabol HM; Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR., Ashby C; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, US; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR., Adhikari M; Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR., Anloague A; Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR., Kaur J; Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR., Khan S; Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR., Choudhury SR; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, US; Pediatric Hematology-Oncology, Arkansas Children's Research Institute, University of Arkansas for Medical Sciences, Little Rock, AR, 72202., Schinke C; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, US; Myeloma Center; University of Arkansas for Medical Sciences, Little Rock, AR., Palmieri M; Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases and Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR., Barnes CL; Department of Orthopedic Surgery; University of Arkansas for Medical Sciences, Little Rock, AR., Ambrogini E; Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases and Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences and Central Arkansas Veterans Healthcare System, Little Rock, AR., Nookaew I; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, US; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR., Delgado-Calle J; Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR, US; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR.
Publikováno v:
Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2606-2618. Date of Electronic Publication: 2024 Aug 01.
Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab.
Autor:
Naqvi S; Myeloma Center University of Arkansas for Medical Sciences Little Rock Arkansas USA., Shrestha A; Myeloma Center University of Arkansas for Medical Sciences Little Rock Arkansas USA., Alzubi M; Department of Internal Medicine University of Jordan Amman Jordan., Alrawabdeh J; Department of Internal Medicine University of Jordan Amman Jordan., Thanendrarajan S; Myeloma Center University of Arkansas for Medical Sciences Little Rock Arkansas USA., Zangari M; Myeloma Center University of Arkansas for Medical Sciences Little Rock Arkansas USA., van Rhee F; Myeloma Center University of Arkansas for Medical Sciences Little Rock Arkansas USA., Schinke C; Myeloma Center University of Arkansas for Medical Sciences Little Rock Arkansas USA., Al Hadidi S; Myeloma Center University of Arkansas for Medical Sciences Little Rock Arkansas USA.
Publikováno v:
EJHaem [EJHaem] 2024 Jul 03; Vol. 5 (4), pp. 789-792. Date of Electronic Publication: 2024 Jul 03 (Print Publication: 2024).
Autor:
Schinke C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Publikováno v:
Chinese clinical oncology [Chin Clin Oncol] 2024 Jun; Vol. 13 (3), pp. 45. Date of Electronic Publication: 2024 Mar 06.